TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6021
+0.0418 (7.46%)
Apr 14, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Surgical & Medical Equipment
41.42M29.46M18.21M15.45M8.27M
Surgical & Medical Equipment Growth
40.58%61.77%17.91%86.68%94.91%
Total
41.42M29.46M18.21M15.45M8.27M
Total Growth
40.58%61.77%17.91%86.68%94.91%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
United States
41.42M29.46M18.21M15.45M8.27M
United States Growth
40.58%61.77%17.91%86.68%94.91%
Total
41.42M29.46M18.21M15.45M8.27M
Total Growth
40.58%61.77%17.91%86.68%94.91%
Source: S&P Global Market Intelligence.